Peer-reviewedCC BYFrontiers in immunology
Mesenchymal stromal cells in age-related neurodegenerative disorders: mechanisms, translational barriers, and precision strategies
- 1Department of Physical Medicine and Rehabilitation, The Affiliated Panyu Central Hospital of Guangzhou Medical University , ,
- 2Rheumatology Medical Center and Stem Cell Intervention Center, Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School , ,
Related
- Bee-Derived Products in Neurodegenerative Diseases: Bioactive Constituents, Redox-Modulating Mechanisms, Evidence, and Translational Perspectives
- Astrocytic GABAergic signaling in perioperative neurocognitive disorders: mechanisms and intervention strategies
- Nanotechnology-based strategies for helminth control: drug delivery, green nanoparticles, mechanisms, and translational barriers.
- Hepatoprotective natural polyphenol extracts: molecular mechanisms, stabilization-delivery strategies, and translational bottlenecks for functional food applications
- Targeting inhibitory phagocytosis checkpoints in cancer immunotherapy: mechanisms, therapeutic strategies, and translational challenges
BibTeX
@article{long2026mesenchymal,
title = {{Mesenchymal stromal cells in age-related neurodegenerative disorders: mechanisms, translational barriers, and precision strategies}},
author = {Zhiyong Long and Honghao Guo and Lingyun Sun},
journal = {Frontiers in immunology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13656211},
note = {CC BY},
}
RIS
TY - JOUR
TI - Mesenchymal stromal cells in age-related neurodegenerative disorders: mechanisms, translational barriers, and precision strategies
AU - Zhiyong Long
AU - Honghao Guo
AU - Lingyun Sun
PY - 2026
DA - 2026/10/16
JO - Frontiers in immunology
UR - https://europepmc.org/article/PMC/PMC13656211
SN - 1664-3224
ER -